Back to Business

Sandoz shares up after $322 million biosimilar deal with Henlius

Business August 17, 2026 at 8:11 AM

Sandoz shares up after $322 million biosimilar deal with Henlius

Investing.com

Read at Investing.com

More Stories

Berenberg upgrades Mobileye stock rating on growth prospects

Berenberg upgrades Mobileye stock rating on growth prospects

🇺🇸 Investing.com 25m ago

Intuit stock analysis: Is it now time to buy the pullback?

Intuit stock analysis: Is it now time to buy the pullback?

🇺🇸 Investing.com 27m ago

Ferrari’s bespoke Luce EV one-off fetches $40 million at charity auction

Ferrari’s bespoke Luce EV one-off fetches $40 million at charity auction

🇺🇸 Investing.com 30m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play